dockets: FDA-2026-P-12350
Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-P-12350 | FDA | Request the FDA determine whether the Reference Listed Drug (RLD) BROMFED-DM (BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE) Oral Syrup, 2 mg/5 mL, 10 mg/5 mL, 30 mg/5 mL; under Abbreviated New Drug Application (ANDA) 088811 held by PHARMOBEDIENT CONSULTING LLC, was voluntarily withdrawn from commercial | Nonrulemaking | 2026-10-13T19:19:46Z | 0b000064b965c4db | list_pull |
Links from other tables
- 3 rows from docket_id in documents